TVM and Tillotts form company to take on ulcerative colitis by John Pinching | Jul 28, 2023 | News | 0 Mage Biologics aims to progress a novel, orally administered monoclonal antibody Read More
MHRA expands use of Tillotts’ Entocort by Selina McKee | Feb 6, 2018 | News | 0 The Medicines and Healthcare Products Regulatory Agency (MHRA) has expanded the approved uses of Tillotts Pharma’s Entocort to include the induction of remission in patients with active microscopic colitis (MC). Read More